CLEVELAND--(BUSINESS WIRE)--ImageIQ, an imaging contract research organization (CRO) and IMARC Research, a CRO offering monitoring, auditing and training services, today announced a partnership that will strengthen the abilities of both organization’s clients to manage the complexities of imaging within clinical trials, and to enhance FDA approvals by ensuring that scientific data is optimized and that processes are compliant. IMARC will bring its 14 years of clinical trial management experience to ImageIQ clients that utilize ImageIQ’s imaging analytics and software development expertise. Conversely, ImageIQ will provide IMARC clients with their imaging and image analysis clinical trial expertise.
“Medical imaging technology and imaging analytics have changed vastly in the past few years, providing whole new strata of clinical trial data,” said Sandra Maddock, CEO and President of IMARC Research. “However, with the addition of various imaging modalities into a clinical trial comes increased complexities and risks that need to be considered and carefully monitored in order to ensure accurate, complete, and evaluable data at the end of the study.” This partnership differentiates IMARC Research as a CRO that can accommodate those added complexities with various risk mitigation approaches including clinical trial monitoring, auditing, and Good Clinical Practice (GCP) training. “We are very excited to enter into this partnership with ImageIQ to bring this level of expertise to our client base,” said Maddock.
“Our clients often begin working with us on innovative ways to utilize imaging within clinical trials, to improve data quality, to quantify product marketing claims, and to strengthen FDA documentation. As a part of that process, they quickly realize that imaging enhances the scientific results that they garner. It is also clear to them that adding imaging requires a sophisticated process to ensure imaging compliance monitoring and auditing process. Our clients are already very pleased that IMARC Research can provide that expertise.”
ImageIQ is an Imaging Contract Research Organization (ICRO) that combines software engineering with biomedical and imaging expertise to provide quantitative visual analysis that enhances R&D and product efficacy/safety testing for research, medical device and pharmaceutical organizations. Incubated within Cleveland Clinic for the better part of a decade, ImageIQ provides customized image analytics and reporting, delivering objective quantitative evidence that speeds time to discovery and market entry, reduces internal overhead and improves grant proposal attractiveness and fundability. By advancing the speed of research, ImageIQ customers can extend their expertise and abilities and complete work quickly, allowing innovative staff members to focus on creative solutions to research. www.Image-IQ.com.
About IMARC Research
A privately-held, 14-year old company located in Strongsville, Ohio, IMARC assists the clinical research community in the pursuit of FDA and worldwide approvals. Our effectiveness is built on preparing, educating, complementing and guiding site teams from Day 1 — to control the complex management of trials via cost-effective monitoring, auditing and training services — which results in the support, proof and assurance they seek to overcome chaos caused by complexity while achieving compliance through consistency. Providing committed, competent and confident consultation is how IMARC sets the highest standards for site outcomes and study partnerships. Sites monitored from the start by IMARC have never received an FDA warning letter. More information is available at: www.imarcresearch.com